tiprankstipranks
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF
US Market
IPHYF
Innate Pharma SA
RESEARCH TOOLSreports
Want to see IPHYF full AI Analyst Report?

Innate Pharma SA (IPHYF) Cash flow

27 Followers

Innate Pharma SA Cash Flow

IPHYF's free cash flow for Q4 2025 was €-21.67M. For the 2025 fiscal year, IPHYF's free cash flow was decreased by €-45.61M and operating cash flow was €-21.59M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
€ -52.76M€ -6.90M€ -32.56M€ -19.15M€ -58.46M
Investing Cash Flow
€ 7.29M€ 9.20M€ 20.63M€ 1.88M€ -917.00K
Financing Cash Flow
€ 6.07M€ -6.01M€ -1.97M€ -1.83M€ 26.82M
End Cash Position
€ 28.09M€ 66.40M€ 70.61M€ 84.22M€ 103.76M
Free Cash Flow
€ -52.90M€ -7.29M€ -34.91M€ -20.28M€ -59.79M
Currency in EUR

Innate Pharma SA Cash Flow